Search NASA⌕ Search

SEARCH · Search NASA

Results for “INVENTION”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 records
All sourcesNASA NTRSDOE OSTI
DOE OSTI2015

Invention as a combinatorial process: evidence from US patents

Invention has been commonly conceptualized as a search over a space of combinatorial possibilities. Despite the existence of a rich literature, spanning a variety of disciplines, elaborating on the recombinant nature of invention, we lack a formal and quantitative characterization of the combinatorial process underpinning inventive activity. Here, we use US patent records dating from 1790 to 2010 to formally characterize invention as a combinatorial process. To do this, we treat patented inventions as carriers of technologies and avail ourselves of the elaborate system of technology codes used by the United States Patent and Trademark Office to classify the technologies responsible for an invention's novelty. We find that the combinatorial inventive process exhibits an invariant rate of ‘exploitation’ (refinements of existing combinations of technologies) and ‘exploration’ (the development of new technological combinations). This combinatorial dynamic contrasts sharply with the creation of new technological capabilities—the building blocks to be combined—that has significantly slowed down. We also find that, notwithstanding the very reduced rate at which new technologies are introduced, the generation of novel technological combinations engenders a practically infinite space of technological configurations.

99 GENERAL AND MISCELLANEOUS↗
DOE OSTI2024

Global trend of methane abatement inventions and widening mismatch with methane emissions

Substantially reducing methane emissions is the fastest way to repress near-term warming and is an essential prerequisite for reaching the 1.5 °C target. However, knowledge about the global invention trend, sectoral and national distribution and international diffusion of methane-targeted abatement technologies (MTATs) remains limited. On the basis of patent data, we identify more than 175,000 MTAT inventions applied between 1990 and 2019 by 133 countries or dependent territories. Our results revealed that after sustained growth of more than fourfold, the number of global high-quality MTAT inventions declined by 3.5% annually from 2010 to 2019. The sectoral and national-level distributions of MTAT inventions and methane emissions are strongly mismatched. Additionally, the international diffusion of MTATs is 11.1% lower than that of overall climate change mitigation technologies and most transfers occur between developed countries or flow to China, South Korea and Brazil; however, other developing countries and the least developed countries are rarely involved.

54 ENVIRONMENTAL SCIENCES↗
DOE OSTI2020

Who Invented the Christy Gadget

The Christy Gadget, named after its principal inventor, is the informal name for the device tested at Trinity on July 16th, 1945. In late 1944, Robert Christy proposed a novel invention that altered the design of the plutonium pit in Fat Man. While scientists originally intended to use a hollow sphere of plutonium, there was a substantial risk given a number of asymmetries that resulted from implosion. Christy proposed changing the design of the plutonium core to a solid sphere of plutonium with a modulated neutron source. The new model was adopted and used in the early implosion bombs. While there is little debate about the important role that Christy played in demonstrating its feasibility as a safe design, there is a debate as to who initially proposed the idea of the Christy Device. My project this summer outlines and resolves this dispute. While Christ does deserve the majority of the credit for the invention and design, I also acknowledge the important role Rudolf Peierls and John von Neumann played in its development.

46 INSTRUMENTATION RELATED TO NUCLEAR SCIENCE AND ↗
DOE OSTI2023

The Power of Invention: National Security Science and Beyond at Los Alamos National Laboratory

According to Webster, a genius is someone who possesses uncommon powers of intellect, particularly the power of invention. Those who call Los Alamos National Laboratory their professional home have a tremendous power of invention — their genius benefits from atomic power. Nuclear weapons are the heart of the Laboratory’s origin story. It is why we are here. They are also central to the multiple innovations inspired and driven by such atomic work — in ways that might surprise you. Our search for solutions outside the realm of nuclear security is nevertheless built on the incredible innovations and challenges driven by a defining moment in our world’s history — the advent of the nuclear weapon.

45 MILITARY TECHNOLOGY, WEAPONRY, AND NATIONAL DEF↗
DOE OSTI2016

Inventing a Better Way to Capture the Energy of Waves

NREL's ocean energy research team's efforts to develop more robust and cost-effective wave energy converters have yielded a record of invention titled, 'Wave Energy Conversion Devices with Actuated Geometry.' This innovative wave device features a wave converter with controlled geometry that increases energy capture and prevents large waves from overloading the generator. The invention's control system actuates flaps that open and close depending on wave conditions. Better control of the wave forces acting on wave energy conversion devices provides a solution to one of wave energy's biggest challenges -- and could cut the cost of wave energy in half.

16 TIDAL AND WAVE POWER↗
DOE OSTI2015

Innovation 101: The story behind the invention of DNATrax

Lawrence Livermore researcher George Farquar shares the story behind the invention of DNATrax, a cost-effective and highly efficient method to accurately trace contaminated food back to its source. Foodborne illnesses kill roughly 3,000 Americans each year and about 1 in 6 are sickened, according to the Centers for Disease Control and Prevention. Yet most contaminated foods are never traced back to their source. That’s because existing methods to track tainted food following its supply chain from table to farm are highly inefficient, jeopardizing the health of millions and costing the food industry billions. A typical process to trace food includes interviewing consumers and suppliers and examining every detail of the supply chain, a tedious method that takes weeks at best to complete.

59 BASIC BIOLOGICAL SCIENCES↗
DOE OSTI2014

MO-F-16A-08: Have An Impact On More Patients From Your Ideas And Inventions

Purpose: To inform physicists how to obtain an FDA 510(k) clearance for the innovations they use in their facility and to make those ideas widely available to patients throughout the U.S. Methods: Give advice from 20 years experience of assisting in well over 100 successful 510(k) clearances. Results: Learn how to develop a 510(k) submission. Conclusion: Many physicists, physicians and radiation therapists have developed innovations that that are helpful to the patients in their institution. But, many of these innovations deserve to be made available to patients throughout the United States. The author, a Certified Radiological Physicist and former FDA employee, has consulted for over twenty years for inventors, start-ups and established medical device manufacturers to bring new devices to market in the U.S. and to assist them to established FDA compliant quality systems for manufacturing. In this presentation the audience will learn the important points for deciding to go forward with obtaining a Premarket Notification clearance [also known as a 510(k) clearance] to legally market a medical device in the United States. The FDA has published guidelines for submitting a 510(k) application. However, the methods used to efficiently develop the documentation for submission and to obtain clearance in the shortest possible time comes from the author's experience in assisting well over one hundred successful 510(k) clearances.Whether you want to start your own company or to market your idea to an established medical device manufacturer, the value of your innovation increases with a documented 510(k) clearance from FDA.

61 RADIATION PROTECTION AND DOSIMETRY↗
DOE OSTI2023

The woman behind the curious invention of modern software: Klára Dán von Neumann’s handwritten letters confirm her legacy

The year 1945 marked not only the birth of the atomic age, but also the birth of modern computer programming. The first fully electronic computing machine, the ENIAC (Electronic Numerical Integrator And Computer), came online in December 1945. But programming the ENIAC was an excruciatingly difficult task. Klára Dán von Neumann, who joined the Laboratory at Los Alamos after WWII, helped to revolutionize the process, creating the very first modern computer programs.

97 MATHEMATICS AND COMPUTING↗
DOE OSTI2018

Inventing Nanoscience: Exploring Materials at Atomic Scale

By 2001, the potential for nanoscience to transform many areas of science was increasingly clear. A Presidential Nanoscience Initiative was launched. Working in collaboration with other federal science agencies, the Basic Energy Sciences (BES) office of DOE proposed and supported the creation of five Nanoscale Science Research Centers open to all scientists, located at DOE National Laboratories to also enable access to existing X-ray and neutron probes. In the decade since these shared research facilities came into full operation, they have enabled an explosion of discoveries in physics, chemistry, materials science and biology, which in turn have begun to yield important new technologies.

77 NANOSCIENCE AND NANOTECHNOLOGY↗
DOE OSTI2014

Protection against herbivores

The present invention relates to genes, proteins and methods comprising molecules that alter amino acid levels. In one embodiment, the present invention relates to altering guanidino substrate hydrolysis activities in plants, arthropods and microorganisms using molecules within the arginase family and other molecules that alter an amino acid levels. In ones embodiment, the present invention relates to altering threonine substrate deamination and dehydration activities in plants, arthropods and microorganisms using molecules within the threonine deaminase family and other molecules that alter amino acid levels. In one embodiment, the present invention relates to using genes, proteins and methods comprising arginase or threonine deaminase for altering the pathophysiology of plants, arthropods and microorganisms. In a preferred embodiment, the present invention relates to altering guanidino substrate hydrolysis activity in plants, arthropods, and microorganisms using arginase. In another preferred embodiment, the invention relates to altering threonine substrated deamination and dehydration activity in plants, arthropods, and microorganisms using threonine deaminase. In some embodiments, the invention related to overexpression and increased activity of arginase, threonine deaminase and a proteinase inhibitor.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2017

Protection against herbivores

The present invention relates to genes, proteins and methods comprising molecules that alter amino acid levels. In one embodiment, the present invention relates to altering guanidino substrate hydrolysis activities in plants, arthropods and microorganisms using molecules within the arginase family and other molecules that alter an amino acid levels. In ones embodiment, the present invention relates to altering threonine substrate deamination and dehydration activities in plants, arthropods and microorganisms using molecules within the threonine deaminase family and other molecules that alter amino acid levels. In one embodiment, the present invention relates to using genes, proteins and methods comprising arginase or threonine deaminase for altering the pathophysiology of plants, arthropods and microorganisms. In a preferred embodiment, the present invention relates to altering guanidino substrate hydrolysis activity in plants, arthropods, and microorganisms using arginase. In another preferred embodiment, the invention relates to altering threonine substrated deamination and dehydration activity in plants, arthropods, and microorganisms using threonine deaminase. In some embodiments, the invention related to overexpression and increased activity of arginase, threonine deaminase and a proteinase inhibitor.

59 BASIC BIOLOGICAL SCIENCES↗
DOE OSTI2018

Uses of monoclonal antibody 8H9

This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides a method of inhibiting the growth of tumor cells comprising contacting said tumor cells with an appropriate amount of monoclonal antibody 8H9 or a derivative thereof.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2015

Methods and materials for deconstruction of biomass for biofuels production

The present invention relates to nucleic acids, peptides, vectors, cells, and plants useful in the production of biofuels. In certain embodiments, the invention relates to nucleic acid sequences and peptides from extremophile organisms, such as SSO1949 and Ce1A, that are useful for hydrolyzing plant cell wall materials. In further embodiments, the invention relates to modified versions of such sequences that have been optimized for production in one or both of monocot and dicot plants. In other embodiments, the invention provides for targeting peptide production or activity to a certain location within the cell or organism, such as the apoplast. In further embodiments, the invention relates to transformed cells or plants. In additional embodiments, the invention relates to methods of producing biofuel utilizing such nucleic acids, peptides, targeting sequences, vectors, cells, and/or plants.

09 BIOMASS FUELS↗